PE  Ampersand Ventures

     Office Locations:

55 William St., Suite 240
Wellesley, MA 02481
Phone: 781-239-0700
Fax: 781-239-0824



  • Middle Market



  • Life Sciences & Healthcare



    Ampersand, a middle market private equity firm focused on investments in two core sectors: Healthcare and industrial. The firm targets middle market, growth equity opportunities where it is the first institutional investor. Ampersand's investment team consists of almost 20 professionals managing more than $600 million from the firm's offices in Wellesley, MA. Ampersand originated in 1969 as an internal, technology-focused venture capital investment activity at PaineWebber. Ampersand was then founded in 1988 as a spinoff from PaineWebber, focused on the specialty materials and chemicals (SMC) industry. Over the past two decades Ampersand has managed $1 billion in private equity partnerships.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Dana Niles Partner and COO
    David Parker General Partner
    Eric B. Lev Partner
    Geoffrey P. Teillon Partner
    Herbert Hooper Managing General Partner


    Portfolio companies include:

      Agilux Laboratories
        web link

      ATS Labs
        web link

      Biomedical Structures
        web link

        web link

      Blue Sky BioServices
        web link

        web link

      CoreLab Partners
        web link

        web link

        web link

      Dynex Technologies
        web link

        web link

      Magellan Biosciences
        web link

      Magellan Diagnostics
        web link

      MedVenture Technology
        web link

      Modified Polymer Components
        web link

      Nitinol Devices and Components
        web link

        web link

      Roadrunner Pharmacy
        web link

      ViraCor-IBT Laboratories
        web link

      Willow Laboratories
        web link


    Recent News:

      There is no recent news for Ampersand Ventures.